𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia

✍ Scribed by Hof, J.; Krentz, S.; van Schewick, C.; Korner, G.; Shalapour, S.; Rhein, P.; Karawajew, L.; Ludwig, W.-D.; Seeger, K.; Henze, G.

Book ID
111642304
Publisher
American Society of Clinical Oncology
Year
2011
Tongue
English
Weight
274 KB
Volume
29
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Survival after relapse in childhood acut
Survival after relapse in childhood acute lymphoblastic leukemia : Impact of site and time to first relapse-the Children's Cancer Group experience
✍ Paul S. Gaynon; Roger P. Qu; Richard J. Chappell; Michael L.Β N. Willoughby; Davi πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 249 KB πŸ‘ 3 views

other childhood cancers. The survival of patients who relapse despite improved therapy continues to be of interest.

Comparison of idarubicin to daunomycin i
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group
✍ Feig, Stephen A.; Ames, Matthew M.; Sather, Harland N.; Steinherz, Laurel; Reid, πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 1003 KB

The outcome of children with acute lymphoblastic leukemia (ALL) and bone marrow relapse has been unsatisfactory largely because of failure to prevent subsequent leukemia relapses. Ninety-six patients were enrolled and received vincristine, prednisone, L-asparaginase, and an anthracycline as reinduc